Article Text

OP0107 Ectopic Lymphoid Neogenesis is Specifically Associated with Activation of the IL-23/IL-17 Pathway in Rheumatoid Synovitis
  1. N. Yeremenko1,
  2. R. Celis2,
  3. L. van Duivenvoorde1,
  4. J. Ramírez2,
  5. S. Marsal3,
  6. J.L. Pablos4,
  7. R. Sanmarti2,
  8. J.D. Cañete2,
  9. D. Baeten1
  1. 1Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands
  2. 2Hospital Clinic of Barcelona and IDIBAPS
  3. 3Hospital de la Vall d'Hebrό, IRVH, Barcelona
  4. 4Instituto de Investigaciόn Hospital 12 de Octubre (I+12), Madrid, Spain


Objectives Ectopic lymphoid neogenesis (ELN) occurs in 30-50% of the rheumatoid synovial samples but its functional relevance remains unknown. As ELN correlates with the degree of tissue inflammation we investigated here whether ELN was associated with specific cytokine profiles.

Methods Paired synovial tissue (ST) (n=63) and fluid (SF) (n=44) was obtained from the inflamed knee joints of rheumatoid arthritis (RA) patients. Synovial inflammation and ELN was determined by immunohistology. CD21L was used as molecular marker of ELN. Cytokine expression was determined by ELISA and quantitative PCR in SF and ST, respectively.

Results 48% of ST displayed ELN by histology. ELN+ samples had increased T and B lymphocyte infiltration (p<0.001) and CD21L expression (p=0.014). SF analysis showed higher expression of IL-23 (p=0.018) and IL-17F (p=0.028) in ELN+ versus ELN- samples, with a similar trend for IL-22 (p=0.070). Other cytokines, including IL-17A, IL-6, TNF, Th1 cytokines and Th2 cytokines, were not different. In ST, IL-23 (p=0.030) mRNA levels were increased in ELN+ samples. Moreover, CD21L expression as molecular marker of ELN correlated significantly with mRNA expression of IL-23 (r=0.70), IL-17F (r=0.42), IL-21 (r=0.30) and IL-22 (r=0.33), but not IL-17A, IL-6 and TNF. The strong correlation between CD21L and IL-23, IL-17F, IL-21 en IL-22 was confirmed in an independent RA ST sample set (n=36).

Conclusions Synovial ELN in RA is specifically associated with increased expression of IL-23/IL-17-related cytokines. Whether patients depicting synovial ELN respond differently to therapeutic targeting of this pathway remains to be determined.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.5179

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.